Literature DB >> 11073976

Analysis of cyclin D3-cdk4 complexes in fibroblasts expressing and lacking p27(kip1) and p21(cip1).

T K Bagui1, R J Jackson, D Agrawal, W J Pledger.   

Abstract

Our studies examined the effects of p27(kip1) and p21(cip1) on the assembly and activity of cyclin D3-cdk4 complexes and determined the composition of the cyclin D3 pool in cells containing and lacking these cyclin-dependent kinase inhibitors. We found that catalytically active cyclin D3-cdk4 complexes were present in fibroblasts derived from p27(kip1)-p21(cip1)-null mice and that immunodepletion of extracts of wild-type cells with antibody to p27(kip1) and/or p21(cip1) removed cyclin D3 protein but not cyclin D3-associated activity. Similar results were observed in experiments assaying cyclin D1-cdk4 activity. Data obtained using mixed cell extracts demonstrated that p27(kip1) interacted with cyclin D3-cdk4 complexes in vitro and that this interaction was paralleled by a loss of cyclin D3-cdk4 activity. In p27(kip1)-p21(cip1)-deficient cells, the cyclin D3 pool consisted primarily of cyclin D3 monomers, whereas in wild-type cells, the majority of cyclin D3 molecules were complexed to cdk4 and either p27(kip1) or p21(cip1) or were monomeric. We conclude that neither p27(kip1) nor p21(cip1) is required for the formation of cyclin D3-cdk4 complexes and that cyclin D3-cdk4 complexes containing p27(kip1) or p21(cip1) are inactive. We suggest that only a minor portion of the total cyclin D3 pool accounts for all of the cyclin D3-cdk4 activity in the cell regardless of whether the cell contains p27(kip1) and p21(cip1).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11073976      PMCID: PMC86501          DOI: 10.1128/MCB.20.23.8748-8757.2000

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  52 in total

1.  The cyclin-dependent kinase inhibitors olomoucine and roscovitine arrest human fibroblasts in G1 phase by specific inhibition of CDK2 kinase activity.

Authors:  F Alessi; S Quarta; M Savio; F Riva; L Rossi; L A Stivala; A I Scovassi; L Meijer; E Prosperi
Journal:  Exp Cell Res       Date:  1998-11-25       Impact factor: 3.905

Review 2.  Inhibitors of the Cip/Kip family.

Authors:  L Hengst; S I Reed
Journal:  Curr Top Microbiol Immunol       Date:  1998       Impact factor: 4.291

3.  An ordered sequence of events is required before BALB/c-3T3 cells become committed to DNA synthesis.

Authors:  W J Pledger; C D Stiles; H N Antoniades; C D Scher
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

4.  Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1).

Authors:  M Cheng; V Sexl; C J Sherr; M F Roussel
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-03       Impact factor: 11.205

5.  Cyclin D-CDK subunit arrangement is dependent on the availability of competing INK4 and p21 class inhibitors.

Authors:  D Parry; D Mahony; K Wills; E Lees
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

Review 6.  The p16INK4a/CDKN2A tumor suppressor and its relatives.

Authors:  M Ruas; G Peters
Journal:  Biochim Biophys Acta       Date:  1998-10-14

7.  Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4.

Authors:  J Kato; H Matsushime; S W Hiebert; M E Ewen; C J Sherr
Journal:  Genes Dev       Date:  1993-03       Impact factor: 11.361

8.  Cyclin D3-associated kinase activity is regulated by p27kip1 in BALB/c 3T3 cells.

Authors:  F Dong; D Agrawal; T Bagui; W J Pledger
Journal:  Mol Biol Cell       Date:  1998-08       Impact factor: 4.138

9.  Regulation of exit from quiescence by p27 and cyclin D1-CDK4.

Authors:  M H Ladha; K Y Lee; T M Upton; M F Reed; M E Ewen
Journal:  Mol Cell Biol       Date:  1998-11       Impact factor: 4.272

10.  Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle.

Authors:  H Matsushime; M F Roussel; R A Ashmun; C J Sherr
Journal:  Cell       Date:  1991-05-17       Impact factor: 41.582

View more
  19 in total

1.  Overall survival in aggressive B-cell lymphomas is dependent on the accumulation of alterations in p53, p16, and p27.

Authors:  M Sánchez-Beato; A I Sáez; I C Navas; P Algara; M Sol Mateo; R Villuendas; F Camacho; A Sánchez-Aguilera; E Sánchez; M A Piris
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

Review 2.  The non-canonical functions of p27(Kip1) in normal and tumor biology.

Authors:  Savitha S Sharma; W Jackson Pledger
Journal:  Cell Cycle       Date:  2016-04-15       Impact factor: 4.534

3.  An Elk transcription factor is required for Runx-dependent survival signaling in the sea urchin embryo.

Authors:  Francesca Rizzo; James A Coffman; Maria Ina Arnone
Journal:  Dev Biol       Date:  2016-05-24       Impact factor: 3.582

4.  Proliferation of hippocampal progenitors relies on p27-dependent regulation of Cdk6 kinase activity.

Authors:  Nicolas Caron; Emmanuelle C Genin; Quentin Marlier; Sébastien Verteneuil; Pierre Beukelaers; Laurence Morel; Miaofen G Hu; Philip W Hinds; Laurent Nguyen; Renaud Vandenbosch; Brigitte Malgrange
Journal:  Cell Mol Life Sci       Date:  2018-05-04       Impact factor: 9.261

5.  Regulated activating Thr172 phosphorylation of cyclin-dependent kinase 4(CDK4): its relationship with cyclins and CDK "inhibitors".

Authors:  Laurence Bockstaele; Hugues Kooken; Frederick Libert; Sabine Paternot; Jacques E Dumont; Yvan de Launoit; Pierre P Roger; Katia Coulonval
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

6.  Novel functions of plant cyclin-dependent kinase inhibitors, ICK1/KRP1, can act non-cell-autonomously and inhibit entry into mitosis.

Authors:  Christina Weinl; Sebastian Marquardt; Suzanne J H Kuijt; Moritz K Nowack; Marc J Jakoby; Martin Hülskamp; Arp Schnittger
Journal:  Plant Cell       Date:  2005-03-04       Impact factor: 11.277

7.  P27Kip1 and p21Cip1 are not required for the formation of active D cyclin-cdk4 complexes.

Authors:  Tapan K Bagui; Subhra Mohapatra; Eric Haura; W J Pledger
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

8.  The CDK4/CDK6 inhibitor PD0332991 paradoxically stabilizes activated cyclin D3-CDK4/6 complexes.

Authors:  Sabine Paternot; Bianca Colleoni; Xavier Bisteau; Pierre P Roger
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

9.  Increased expression of CDK11p58 and cyclin D3 following spinal cord injury in rats.

Authors:  Yuhong Ji; Feng Xiao; Linlin Sun; Jing Qin; Shuxian Shi; Junling Yang; Yonghua Liu; Dan Zhou; Jian Zhao; Aiguo Shen
Journal:  Mol Cell Biochem       Date:  2007-11-16       Impact factor: 3.396

10.  Blockade of protein geranylgeranylation inhibits Cdk2-dependent p27Kip1 phosphorylation on Thr187 and accumulates p27Kip1 in the nucleus: implications for breast cancer therapy.

Authors:  Aslamuzzaman Kazi; Adam Carie; Michelle A Blaskovich; Cynthia Bucher; Van Thai; Stacy Moulder; Hairuo Peng; Dora Carrico; Erin Pusateri; Warren J Pledger; Norbert Berndt; Andrew Hamilton; Saïd M Sebti
Journal:  Mol Cell Biol       Date:  2009-02-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.